Opendata, web and dolomites

SupaSteD

Suppresion of adaptive immunity by the Salmonella effector SteD

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SupaSteD project word cloud

Explore the words cloud of the SupaSteD project. It provides you a very rough idea of what is the project "SupaSteD" about.

serovars    holden    clinical    pathogenicity    natural    thereby    pathogenesis    wild    causing    island    broad    effector    spi    manipulation    typhimurium    histocompatibility    group    immune    typhoid    mechanistic    mouse    surface    sequence    newly    additional    significance    models    showing    acute    class    chance    first    mutant    serovar    antigen    secretion    therapeutic    infection    sted    centre    found    acid    mrc    cell    indicating    gene    globally    modulator    influence    activation    director    functions    virulence    molecular    pathogens    mice    bacteriology    enterica    bacterial    reduces    world    significantly    encoded    mhcii    human    salmonella    explore    delayed    physiological    supervisor    fever    chronic    cmbi    formulations    presenting    typhi    localised    dendritic    c57bl    mature    leader    levels    amino    adaptive    model    vivo    imperial    vaccines    stm    t3ss    college    prof    paratyphi    cells    preliminary    pathogen    variation    dna    onset    london    delta    immunity   

Project "SupaSteD" data sheet

The following table provides information about the project.

Coordinator
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE 

Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD
city: LONDON
postcode: SW7 2AZ
website: http://www.imperial.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.imperial.ac.uk/people/o.cerny/page/msca-if-supasted.html
 Total cost 195˙454 €
 EC max contribution 195˙454 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-09-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) coordinator 195˙454.00

Map

 Project objective

In this project, I propose to characterize the influence of SteD, an effector of a globally important bacterial pathogen Salmonella enterica, on T cell development, and its potential therapeutic application. In the mouse model of S. enterica infection, the onset of the specific immune responses is delayed significantly in comparison to other bacterial pathogens. Recent work by the group of Prof. Holden, who is the supervisor of this project, a world leader in the field of Salmonella pathogenesis and the Director of the MRC Centre for Molecular Bacteriology and Infection (MRC-CMBI) at Imperial College London, identified SteD, an effector of the Type III Secretion System (T3SS) encoded by Salmonella pathogenicity island 2 (SPI-2), as the first example of a virulence factor that reduces surface-localised mature Major Histocompatibility Complex class II (MHCII) levels in Dendritic Cells. In addition, I have found an increased activation of T cells following infection of C57BL/6 mice with S. enterica serovar Typhimurium (STm) ΔsteD mutant in comparison to wild-type STm, thereby showing that SteD is an important modulator of adaptive immunity in vivo. SteD and/or its gene have a high chance of having therapeutic application. I also have obtained preliminary evidence indicating that SteD has additional functions in the manipulation of antigen-presenting cells. Therefore, I propose to use both the acute and chronic mouse models of Salmonella infection to further characterize the influence of SteD on T cell development. Furthermore, I will investigate the mechanistic and physiological significance of natural variation in the amino acid sequence of SteD among a broad range of S. enterica serovars, including the typhoid fever-causing human-adapted serovars Typhi and Paratyphi. Finally, I will explore the possible use of SteD in new formulations of DNA vaccines. These studies will provide important knowledge for the clinical application of this newly described T3SS effector.

 Publications

year authors and title journal last update
List of publications.
2019 Ondrej Cerny, David W. Holden
Salmonella SPI-2 type III secretion system-dependent inhibition of antigen presentation and T cell function
published pages: , ISSN: 0165-2478, DOI: 10.1016/j.imlet.2019.01.006
Immunology Letters 2020-01-23
2019 Camilla Godlee, Ondrej Cerny, Charlotte H. Durkin, David W. Holden
SrcA is a chaperone for the Salmonella SPI-2 type three secretion system effector SteD
published pages: 15-25, ISSN: 1350-0872, DOI: 10.1099/mic.0.000732
Microbiology 165/1 2020-01-23

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SUPASTED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SUPASTED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

CoCoNat (2019)

Coordination in constrained and natural distributed systems

Read More  

TOPOCIRCUS (2019)

Simulations of Topological Phases in Superconducting Circuits

Read More  

Cartesian Networks (2020)

Cartesian Networks in Early Modern Europe: A Quantitative and Interdisciplinary Approach

Read More